Inflammatory Bowel Disease and malignancy: What are the predictors of malignancy in Inflammatory Bowel Disease?

被引：0
|
作者：
Istemihan, Z. [1 ]
Cavus, B. [1 ]
Bardak, A. E. [2 ]
Kirkoglu, A. M. [2 ]
Kiziltas, C. [2 ]
Silay, R. [2 ]
Senkal, I. V. [1 ]
Imanov, Z. [1 ]
Nuriyev, K. [1 ]
Rustemzade, A. [1 ]
Genc, S. [1 ]
Gulluoglu, M. [3 ]
Ormeci, A. Cifcibasi [1 ]
Demir, K. [1 ]
Besisik, F. [1 ]
Kaymakoglu, S. [1 ]
Akyuz, F. [1 ]
机构：
[1] Istanbul Univ, Istanbul Fac Med, Dept Internal Med, Div Gastroenterohepatol, Istanbul, Turkiye
[2] Istanbul Univ, Istanbul Fac Med, Dept Internal Med, Istanbul, Turkiye
[3] Istanbul Univ, Istanbul Fac Med, Dept Pathol, Istanbul, Turkiye
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P316
引用
收藏
页码：456 / 456
页数：1
相关论文
共 50 条
  • [31] Malignancy and Mortality in Pediatric-onset Inflammatory Bowel Disease: A Systematic Review
    Aardoom, Martine A.
    Joosse, Maria E.
    de Vries, Andrica C. H.
    Levine, Arie
    de Ridder, Lissy
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (04) : 732 - 741
  • [32] Review article: malignancy on thiopurine treatment with special reference to inflammatory bowel disease
    Smith, M. A.
    Irving, P. M.
    Marinaki, A. M.
    Sanderson, J. D.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (02) : 119 - 130
  • [33] The Risk of Malignancy Associated with the Use of Biological Agents in Patients with Inflammatory Bowel Disease
    Dulai, Parambir S.
    Siegel, Corey A.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2014, 43 (03) : 525 - +
  • [34] MALIGNANCY RISK IN VETERAN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A RETROSPECTIVE COHORT STUDY
    Gandle, Cassandra
    Hou, Jason K.
    INFLAMMATORY BOWEL DISEASES, 2019, 25 : S33 - S33
  • [35] Risk of malignancy in paediatric inflammatory bowel disease: results from the DEVELOP registry
    Dubinsky, M.
    Hyams, J.
    Baldassano, R.
    Colletti, R.
    Cucchiara, S.
    Escher, J.
    Faubion, W.
    Fell, J.
    Gold, B.
    Griffiths, A.
    Koletzko, S.
    Kugathasan, S.
    Markowitz, J.
    Ruemmele, F.
    Veerman, G.
    Winter, H.
    Masel, N.
    Tang, K.
    Thayu, M.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S79 - S80
  • [36] Chemotherapy Tolerance and Oncologic Outcomes in Patients with Inflammatory Bowel Disease and Gastrointestinal Malignancy
    Axelrad, Jordan
    Itzkowitz, Steven
    Colombel, Jean-Frederic
    Harpaz, Noam
    Holcombe, Randall
    Ozbek, Umut
    Ang, Celina
    INFLAMMATORY BOWEL DISEASES, 2016, 22 : S32 - S33
  • [37] Disease exacerbation is common in inflammatory bowel disease patients treated with immune checkpoint inhibitors for malignancy
    Rubin, Samuel J. S.
    Balabanis, Tatiana
    Gubatan, John
    Habtezion, Aida
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (06) : 1787 - 1794
  • [38] Disease exacerbation is common in inflammatory bowel disease patients treated with immune checkpoint inhibitors for malignancy
    Samuel J S Rubin
    Tatiana Balabanis
    John Gubatan
    Aida Habtezion
    World Journal of Clinical Cases, 2022, (06) : 1787 - 1794
  • [39] Inflammatory bowel disease: What is new?
    Marteau, P
    Daniel, F
    Seksik, P
    Jian, R
    ENDOSCOPY, 2004, 36 (02) : 130 - 136
  • [40] WHAT IS INFLAMMATORY BOWEL-DISEASE
    DACOSTA, LR
    CANADIAN JOURNAL OF GASTROENTEROLOGY, 1993, 7 (06): : 503 - 508
12345